US Patent

US9907859 — ST-246 liquid formulations and methods

Method of Use · Assigned to Siga Technologies Inc · Expires 2031-08-02 · 5y remaining

Vulnerability score 76/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a process for making the formulation.

USPTO Abstract

The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3377`	—

Patent Metadata

Patent number: US9907859
Jurisdiction: US
Classification: Method of Use
Expires: 2031-08-02
Drug substance claim: No
Drug product claim: No
Assignee: Siga Technologies Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.